{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:10:25Z","timestamp":1771013425316,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jfo.2010.01.008","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T05:46:25Z","timestamp":1267076785000},"page":"152-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacit\u00e9 de l\u2019interf\u00e9ron alpha dans le traitement des \u0153d\u00e8mes maculaires uv\u00e9itiques r\u00e9fractaires au traitement cortico\u00efde et\/ou immunosupresseur"],"prefix":"10.1016","volume":"33","author":[{"given":"V.","family":"Paire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2010.01.008_bib1","first-page":"p.553","article-title":"Cystoid macular edema In: Ocular infection and immunity.","author":"Tessler","year":"1996","journal-title":"Mosby"},{"key":"10.1016\/j.jfo.2010.01.008_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9394(14)71395-9","article-title":"Role of the vitreous in the prognosis of peripherical uveitis","volume":"116","author":"Hikichi","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bjo.84.5.542","article-title":"Macular edema: The role of soluble mediators","volume":"84","author":"Kent","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib4","first-page":"315","article-title":"Vitr\u00e9 et inflammation.","author":"Brasseur","year":"2003","journal-title":"In\u00a0: Pathologie du vitr\u00e9. Masson, Paris"},{"key":"10.1016\/j.jfo.2010.01.008_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9394(56)91653-1","article-title":"Prednisone and prednisolone in ocular disease","volume":"41","author":"Gordon","year":"1956","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00407749","article-title":"Behcet's syndrome: Treatment with recombinant leukocyte alpha-interferon","volume":"278","author":"Tsambaos","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jfo.2010.01.008_bib8","first-page":"33","article-title":"Interferon-alpha 2b for refractory ocular Beh\u00e7et's disease","volume":"344","author":"Feron","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2010.01.008_bib9","first-page":"293","article-title":"The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Beh\u00e7et's disease)","volume":"196","author":"S\u00e1nchez Rom\u00e1n","year":"1996","journal-title":"Rev Clin Exp"},{"key":"10.1016\/j.jfo.2010.01.008_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.0007-0963.2001.04570.x","article-title":"Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases","volume":"146","author":"Cogrel","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jfo.2010.01.008_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.1780250407","article-title":"Serum interferon levels in patients with systemic lupus erythematosus","volume":"25","author":"Ytterberg","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jfo.2010.01.008_bib12","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1167\/iovs.06-0058","article-title":"Interferon-alpha: A Key Factor in Autoimmune Disease?","volume":"47","author":"Plskova","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2010.01.008_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1189\/jlb.71.4.565","article-title":"Interferon alpha as an immunotherapeutic protein","volume":"71","author":"Brassard","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jfo.2010.01.008_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review","volume":"157","author":"Dieperink","year":"2000","journal-title":"Am J Pyschiatry"},{"key":"10.1016\/j.jfo.2010.01.008_bib15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group.","volume":"321","author":"Davis","year":"1989","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jfo.2010.01.008_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241\u00a0patients with chronic viral hepatitis treated with alfa interferon.","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfo.2010.01.008_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2005.07.026","article-title":"Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis","volume":"44","author":"D\u2019Alteroche","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfo.2010.01.008_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2006-926593","article-title":"Interferon causes ischemic ocular diseases--case studies and review of the literature","volume":"223","author":"Stoffelns","year":"2006","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.jfo.2010.01.008_bib20","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2004.043968","article-title":"Is screening for interferon retinopathy in hepatitis C justified?","volume":"88","author":"Cuthbertson","year":"2004","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.jfo.2010.01.008_bib21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","article-title":"Results of interferon-alfa therapy in patients with Beh\u00e7et uveitis","volume":"244","author":"Tugal-Tutkun","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.jfo.2010.01.008_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2007.03.050","article-title":"Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis","volume":"144","author":"Plskova","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45\u00a0patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib24","first-page":"303","article-title":"Texte de consensus sur le traitement de l\u2019h\u00e9patite virale C","volume":"26","author":"Gastro-Ent\u00e9rologie","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jfo.2010.01.008_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Beh\u00e7et's disease with sight threatening posterior or panuveitis","volume":"87","author":"K\u00f6tter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kem199","article-title":"Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease","volume":"46","author":"Guillaume-Czitrom","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfo.2010.01.008_bib27","first-page":"23","article-title":"Efficacit\u00e9 et tol\u00e9rance des immunoglobulines intraveineuses dans le traitement de la r\u00e9tinochoro\u00efdopathie de type Birdshot","volume":"25","author":"Cassoux","year":"2002","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9394(14)77814-6","article-title":"Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents","volume":"96","author":"Nussenblatt","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2010.01.008_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ophtha.2004.12.036","article-title":"Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy","volume":"112","author":"Kiss","year":"2005","journal-title":"Ophthalomology"},{"key":"10.1016\/j.jfo.2010.01.008_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/eye.1989.39","article-title":"Low-dose cyclosporin A therapy in chronic posterior uveitis","volume":"3","author":"Towler","year":"1989","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2010.01.008_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.iae.0000244265.75771.71","article-title":"Interferon alfa-2a: A new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study","volume":"26","author":"Deuter","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2010.01.008_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis","volume":"29","author":"Young","year":"2001","journal-title":"Clin Experiment Ophthalmol."},{"key":"10.1016\/j.jfo.2010.01.008_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IAE.0b013e318030c517","article-title":"Retinal toxicity of intravitreal kenalog in albino rabbits","volume":"27","author":"Lang","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2010.01.008_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/jop.2006.125","article-title":"Safety profile of intravitreal triamcinolone acetonide","volume":"23","author":"Baath","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2010.01.008_bib35","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ophtha.2007.05.037","article-title":"Adverse events after intravitreal triamcinolone in patients with and without uveitis","volume":"114","author":"Galor","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2010.01.008_bib36","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2006.11.028","article-title":"Intravitreal bevacizumab for treatment of uveitic macular edema","volume":"114","author":"Cordero Coma","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2010.01.008_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","article-title":"New approaches in the treatment of adamantiades-Behcet's disease","volume":"18","author":"Pipitone","year":"2006","journal-title":"Curr Opin Rheumatol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551210000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551210000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:01:36Z","timestamp":1759258896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551210000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0181551210000343"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2010.01.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 de l\u2019interf\u00e9ron alpha dans le traitement des \u0153d\u00e8mes maculaires uv\u00e9itiques r\u00e9fractaires au traitement cortico\u00efde et\/ou immunosupresseur","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2010.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}